Endo International PLC (NASDAQ:ENDP)

3.88
Delayed Data
As of Sep 13
 -0.08 / -2.02%
Today’s Change
1.97
Today|||52-Week Range
18.50
-46.85%
Year-to-Date
Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up
Sep 11 / Zacks.com - Paid Partner Content
Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation
Sep 06 / Zacks.com - Paid Partner Content
Endo Files BLA for CCH With the FDA for Cellulite Candidate (Revised)
Sep 10 / Zacks.com - Paid Partner Content
Why Endo International Shares Are Tanking Today
Sep 05 / MotleyFool.com - Paid Partner Content
Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties
Sep 09 / Zacks.com - Paid Partner Content
Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease
Sep 05 / Zacks.com - Paid Partner Content
Endo International Files BLA for Label Expansion of Xiaflex
Sep 09 / Zacks.com - Paid Partner Content
Endo (ENDP) Up 5.8% Since Last Earnings Report: Can It Continue?
Sep 04 / Zacks.com - Paid Partner Content
Why Endo International Stock Is Soaring Today
Sep 06 / MotleyFool.com - Paid Partner Content
Allergan Settles Ahead of Multi-District Opioid Litigation
Sep 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.96
Today’s open4.07
Day’s range3.82 - 4.26
Volume5,457,338
Average volume (3 months)6,570,720
Market cap$878.4M
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+49.45%
Earnings growth (this year)-25.23%
Earnings growth (next 5 years)-4.40%
Revenue growth (last year)-15.04%
P/E ratioNM
Price/Sales0.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+0.45+4.25%
HSKAHeska Corp+2.85+4.44%
MISTMilestone Pharmaceut...+0.16+0.72%
CLLSCellectis SA+0.07+0.56%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)$0.52
Annual revenue (last year)$2.9B
Annual profit (last year)-$1.0B
Net profit margin-32.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts